Endoscopic stent placement in the management of esophagojejunal anastomosis leakage
DOI:
https://doi.org/10.30978/GS-2024-4-44Keywords:
gastric cancer, total gastrectomy, anastomotic leakage, intraluminal stentAbstract
Objective — to evaluate the effectiveness of endoscopic stent placement compared to surgical methods for the management of esophagojejunal anastomosis leakage (AL) after gastrectomy at the National Cancer Institute (NCI) from November 2017 to November 2019.
Materials and methods. The study included patients receiving treatment at the Upper Gastrointestinal Oncology Department of the National Cancer Institute between November 2017 and November 2019. Throughout this period, 186 total gastrectomies were performed. 13 (6.9%) patients developed an anastomotic leak in the postoperative period. All patients had Roux‑en‑Y esophagojejunostomy. 6 patients (46.1%) underwent endoscopic stent placement in the AL area, along with perianastomotic drainage positioning and enteral feeding via a naso‑intestinal tube. Of the remaining patients, 7 (53.9%) underwent surgical treatment, including esophagostomy or esophageal stump formation with a nutritional jejunostomy. This manuscript employed methods of descriptive statistics.
Results. Endoscopic stent placement was successful for 5 patients. Complete defect closure following stent placement was confirmed in 5 patients (83.3%) using endoscopic and radiological methods. The mean hospital stay in the stent group was 15.4 days (range: 9—22 days). The mean time for endoscopic stent removal during rehospitalization was 49.5 (33—62 days) days after initial placement. Complications associated with AL, specifically sepsis resulting from infection in the AL area, led to the death of 1 (16.7%) patient in the stent group. Surgical treatment was successful in 5 patients (71.4%). 2 patients (28.6%) died due to infectious complications and multiple organ failure syndrome. The average hospital stay for surgical patients was 32.8 (19—40) days. Mortality rates were 16.7% and 28.6% for the stent placement and surgical groups, respectively.
Conclusions. Endoscopic endoluminal stent placement in the area of AL using self‑expandable metallic stents combined with local drainage and enteral nutrition is a promising method for treating esophagojejunal anastomotic leakage after total gastrectomy. This study demonstrates that endoscopic stent placement reduces hospital stay and mortality rates compared to surgical methods. Endoscopic stent placement provides effective defect closure with fewer complications. However, surgical treatment remains indispensable in cases of severe sepsis or failure of conservative methods, despite the high mortality risk. Further studies are needed to develop standardized approaches for selecting treatment methods based on leak size and the patient’s overall condition.
References
Ajani JA, D’Amico TA, Bentrem DJ, et al. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network: JNCCN. 2022;20(2):167-92. https://doi.org/10.6004/jnccn.2022.0008.
Al-Batran, Salah-Eddin et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet. 2019;393(10184):1948-57. http://doi.org/10.1016/S0140-6736(18)32557-1.
Aurello P, Magistri P, D’Angelo F, et al. Treatment of esophagojejunal anastomosis leakage: a systematic review from the last two decades. The American Surgeon. 2015;81(5):450-3.
Baiocchi GL, Giacopuzzi S, Reim D, et al. Incidence and grading of complications after gastrectomy for cancer using the GASTRODATA registry: a European retrospective observational study. Ann Surg. 2020;272:807-13.
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024 May-Jun;74(3):229-63. http://doi.org/10.3322/caac.21834. Epub 2024 Apr 4. PMID: 38572751.
Carboni F, Valle M, Federici O, et al. Esophagojejunal anastomosis leakage after total gastrectomy for esophagogastric junction adenocarcinoma: options of treatment. J Gastrointest Oncol. 2016;7(4):515-22.
Cengiz M, Odemis B, Durak MB. Endoscopic treatment of esophagogastric and esophagojejunal anastomotic leaks: A single tertiary center experience. Medicine. 2023;102(41):e35582. https://doi.org/10.1097/MD.0000000000035582.
Doosti-Irani A, Mansournia MA, Cheraghi Z, Rahimi-Foroushani A, Haddad P, Holakouie-Naieni K. Network meta-analysis of palliative treatments in patients with esophageal cancer. Critical Reviews in Oncology/Hematology. 2021;168:103506. https://doi.org/10.1016/j.critrevonc.2021.103506.
Fabbi M, Hagens ERC, van Berge Henegouwen MI, Gisbertz SS. Anastomotic leakage after esophagectomy for esophageal cancer: definitions, diagnostics, and treatment. Dis Esophagus. 2021;34(1):doaa039. http://doi.org/10.1093/dote/doaa039.
Feith M, Gillen S, Schuster T, Theisen J, Friess H, Gertler R. Healing occurs in most patients that receive endoscopic stents for anastomotic leakage; dislocation remains a problem. Clin Gastroenterol Hepatol. 2011;9(3):202-10.
Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer; 2018 [03/20/2019].
Girard E, Messager M, Sauvanet A, et al. Anastomotic leakage after gastrointestinal surgery: diagnosis and management. J Visc Surg. 2014;151(6):441-50.
Gong W, Li J. Combat with esophagojejunal anastomotic leakage after total gastrectomy for gastric cancer: A critical review of the literature. International Journal of Surgery. 2017;47:18-24. https://doi.org/10.1016/j.ijsu.2017.09.019.
Hoeppner J, Kulemann B, Seifert G, et al. Covered self-expanding stent treatment for anastomotic leakage: outcomes in esophagogastric and esophagojejunal anastomoses. Surgical Endoscopy. 2014;28(5):1703-11. https://doi.org/10.1007/s00464-013-3379-4.
Kim SY, Kang CH, Park IK, Kim YT. Esophageal stent insertion for postesophagectomy anastomosis site leakage. Clin Exp Otorhinolaryngol. 2016;9(4):382-4. http://doi.org/10.21053/ceo.2015.00724.
Kim YI, Lee JY, Khalayleh H, Kim CG, et al. Efficacy of endoscopic management for anastomotic leakage after gastrectomy in patients with gastric cancer. Surgical endoscopy. 2022;36(5):2896-905. https://doi.org/10.1007/s00464-021-08582-z.
Kim YJ, Shin SK, Lee HJ, et al. Endoscopic management of anastomotic leakage after gastrectomy for gastric cancer: How efficacious is it? Scand J Gastroenterol. 2013;48(1):111-8.
Kirkilevsky SI, Krahmalyov PS, Frydel RI. The results of stenting patients with upper-third and middle-third esophageal cancer. National Cancer Institute, Kyiv. . https://doi.org/10.32471/clinicaloncology.2663-466X.38.22537 (Ukrainian).
Lordick F, Carneiro F, Cascinu S, et al. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(10):1005-20. http://doi.org/10.1016/j.annonc.2022.07.004.
Maejima K, Taniai N, Yoshida H. Risk factors for esophagojejunal anastomotic leakage in gastric cancer patients after total gastrectomy. J Nippon Med Sch. 2023;90(1):64-8. http://doi.org/10.1272/jnms.JNMS.2023_90-111.
Makuuchi R, Irino T, Tanizawa Y, et al. Esophagojejunal anastomotic leakage following gastrectomy for gastric cancer. Surg Today. 2019;49:187-96. https://doi.org/10.1007/s00595-018-1726-8.
Meyer L, Meyer F, Dralle H, et al. Insufficiency risk of esophagojejunal anastomosis after total abdominal gastrectomy for gastric carcinoma. Langenbecks Arch Surg. 2005;390:510-16.
Pattynama LMD, Pouw RE, Henegouwen MIVB, et al. Endoscopic vacuum therapy for anastomotic leakage after upper gastrointestinal surgery. Endoscopy. 2023;55(11):1019-25. https://doi.org/10.1055/a-2102-1691.
Raimondo D, Sinagra E, Facella T, et al. Self-expandable metal stent placement for closure of a leak after total gastrectomy for gastric cancer: report on three cases and review of the literature. Case reports in Gastrointestinal Medicine. 2014;2014:409283. https://doi.org/10.1155/2014/409283.
Seicean RI, Puscasu D, Gheorghiu A, Pojoga C, Seicean A, Dindelegan G. Anastomotic Leakage after Gastrectomy for Gastric Cancer. Journal of gastrointestinal and liver diseases: JGLD. 2023;32(4):526-35. https://doi.org/10.15403/jgld-5238.
Sierzega M, Kolodziejczyk P, Kulig J, Polish Gastric Cancer Study G. Impact of anastomotic leakage on long-term survival after total gastrectomy for carcinoma of the stomach. Br J Surg. 2010;97(7):1035-42.
Tokunaga M, Tanizawa Y, Bando E, Kawamura T, Terashima M. Poor survival rate in patients with postoperative intra-abdominal infectious complications following curative gastrectomy for gastric cancer. Ann Surg Oncol. 2013;20(5):1575-83.
Ubels S, Verstegen MHP, Klarenbeek BR, et al. Treatment of anastomotic leak after oesophagectomy for oesophageal cancer: large, collaborative, observational TENTACLE cohort study. Br J Surg. 2023;110(7):852-63. http://doi.org/10.1093/bjs/znad123.
Yang WJ, Zhao HP, Yu Y, et al. Updates on global epidemiology, risk and prognostic factors of gastric cancer. World J Gastroenterol. 2023;29(16):2452-68. http://doi.org/10.3748/wjg.v29.i16.2452.
Yoo HM, Lee HH, Shim JH, Jeon HM, Park CH, Song KY. Negative impact of leakage on survival of patients undergoing curative resection for advanced gastric cancer. J Surg Oncol. 2011;104(7):734-40.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Authors
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.